Glucagon-like peptide-1 receptor agonists and risk of suicidality among patients with type 2 diabetes: active comparator, new user cohort study

Scritto il 28/04/2025
da

No abstract

BMJ. 2025 Apr 28;389:r845. doi: 10.1136/bmj.r845.

NO ABSTRACT

PMID:40294951 | PMC:PMC12036536 | DOI:10.1136/bmj.r845